Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|December 16, 1991
Evidence for a reverse transcription intermediate for a marked line transposon in tumoral rat cellsE Segal-Bendirdjian, T Heidmann
Bulletin Du Cancer|May 1, 1996
[Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis]E Segal-Bendirdjian, A Jacquemin-Sablon
Experimental Cell Research|May 1, 1995
Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic processE Segal-Bendirdjian, A Jacquemin-Sablon
The EMBO Journal|April 1, 1993
Generation of processed pseudogenes in murine cellsT Tchénio, E Segal-Bendirdjian, T Heidmann
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2001
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiationF Pendino, M Flexor, F Delhommeau, et al.
Anti-Cancer Drug Design|February 1, 1990
Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactionsB Lambert, E Segal-Bendirdjian, C Esnault, et al.
Biochemical Pharmacology|January 1, 1990
Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agentC Esnault, S C Brown, E Segal-Bendirdjian, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Isolation and characterization of mitochondrial DNA-less lines from various mammalian cell lines by application of an anticancer drug, ditercaliniumK Inoue, D Takai, H Hosaka, et al.
Pageof 2